OMID Engages PCAOB Audit Firm; Targets OTCQB Up-List
OMID Engages PCAOB Audit Firm; Targets OTCQB Up-List
Phillipsburg, NJ, Dec. 21, 2021 (GLOBE NEWSWIRE) -- OMID Holdings, Inc. (OTC Pink: OMID) is pleased to announce that it has retained M&K CPAS, PLLC, a PCAOB registered accounting and auditing firm, to perform an audit of the company's financial statements for the years ending in 2020, 2021, and 2022. M&K has extensive audit experience and specializes in working with public companies across the United States. The audits for the years ending in 2020 and 2021 are expected to begin immediately with a target completion date in the second quarter of 2022. Upon successful completion of these activities, the company expects to become SEC-reporting and up-list to the OTCQB.
環球通訊社新澤西州菲利普斯堡2021年12月21日電OMID控股公司(場外粉色代碼：OMID)高興地宣佈，它已聘請PCAOB註冊會計和審計公司M&K CPAS，PLLC對公司截至2020年、2021年和2022年的財務報表進行審計。瑪莎百貨擁有豐富的審計經驗，擅長與美國各地的上市公司合作。預計在2020年和2021年結束的年度的審計將立即開始，目標完成日期為2022年第二季度。在成功完成這些活動後，該公司預計將成為美國證券交易委員會的報告對象，併成為場外交易市場質量局的上榜公司。
"As one of the key objectives for 2021, we have initiated an audit in preparation of a subsequent up-list. This activity, combined with our rapid growth and operational success, is expected to significantly improve the liquidity of OMID stock, vastly expanding the audience of potential investors ranging from retail and accredited to institutional investors." stated Adam Frank, the Chairman & CEO of OMID Holdings, Inc.
“作為2021年的主要目標之一，我們已經啟動了一項審計，為隨後的上榜做準備。這一活動，再加上我們的快速增長和運營成功，預計將顯著改善OMID股票的流動性，極大地擴大潛在投資者的受眾，從散户和認可投資者到機構投資者。”奧米德控股公司(Omid Holdings，Inc.)董事長兼首席執行官亞當·弗蘭克(Adam Frank)表示。
About OMID Holdings, Inc.
OMID Holdings, Inc. is a publicly-traded (OTC Pink: OMID) Florida corporation which focuses on developing and manufacturing various health and wellness products at its FDA-registered manufacturing facility in Phillipsburg, NJ. With a diverse portfolio of product types, OMID specializes in formulations which contain cannabis extracts, primarily CBD, as well as other herbal ingredients. The company's objective is to provide quality, integrity, and value with notable consumer benefits derived from all of its finished goods. Acts 2:12.
For more information about the company, please visit .
關於奧米德控股公司
奧米德控股公司是一家在佛羅裏達州上市(場外交易市場代碼：OMID)的公司，專注於在新澤西州菲利普斯堡的FDA註冊製造廠開發和製造各種保健和保健產品。憑藉多樣化的產品類型組合，奧米德專門生產含有大麻提取物(主要是CBD)以及其他草本成分的配方。該公司的目標是提供質量、誠信和價值，並從其所有成品中獲得顯著的消費者利益。使徒行傳2：12。
欲瞭解更多有關該公司的信息，請訪問。
Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
“安全港法案”：前瞻性陳述包含在1933年“證券法”第27A節和修訂後的1934年“證券交易法”第21E節的含義之內。本公司所有有關預期未來財務狀況、經營結果、現金流、融資計劃、業務戰略、產品和服務、競爭地位、增長機會、計劃和未來經營目標的表述，包括“預期”、“如果”、“相信”、“計劃”、“估計”、“預期”、“打算”、“可能”、“可能”、“應該”、“將會”和其他類似表述，均為前瞻性表述，涉及風險、不確定性和或有事項。其中許多是我們無法控制的，這可能會導致實際結果、績效或成就與預期的結果、績效或成就大不相同。我們沒有義務(明確拒絕任何此類義務)更新或改變我們的前瞻性陳述，無論是由於新信息、未來事件還是其他原因。
Contact:
聯繫方式：
Adam Frank
Phone: +1 908-386-2880
Email: info@omidholdingsinc.com
亞當·弗蘭克
電話：+1 908-386-2880
電子郵件：info@omidholdingsinc.com
譯文內容由第三人軟體翻譯。